Cargando…

What Is Disease?

Detalles Bibliográficos
Autor principal:	Hanaford, J. H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	1888
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9236343/ https://www.ncbi.nlm.nih.gov/pubmed/36491983

Ejemplares similares

Acid Drinks
por: Hanaford, J. H.
Publicado: (1883)

A Cold in the Head
por: Hanaford,
Publicado: (1890)

The immune system as a driver of mitochondrial disease pathogenesis: a review of evidence
por: Hanaford, Allison, et al.
Publicado: (2022)

Neonatal Brain Injury and Genetic Causes of Adult-Onset Neurodegenerative Disease in Mice Interact With Effects on Acute and Late Outcomes
por: Martin, Lee J., et al.
Publicado: (2019)

AAV-vector based gene therapy for mitochondrial disease: progress and future perspectives
por: Hanaford, Allison R., et al.
Publicado: (2022)

Volatile anaesthetic toxicity in the genetic mitochondrial disease Leigh syndrome
por: Spencer, Kira A., et al.
Publicado: (2023)

Targeting Notch signaling as a novel therapy for retinoblastoma
por: Asnaghi, Laura, et al.
Publicado: (2016)

What Is a Disease: What Is the Meaning of Diagnosis?
por: Macilwaine, Sydney W.
Publicado: (1907)

What Is Understood by a Disease Entity?
por: Wulff, H. R.
Publicado: (1979)

Autoinflammatory diseases: what is behind them and what is new?
por: Maalouly, Michele, et al.
Publicado: (2022)

What Is Disease?
por: Dyas, W. Godfrey
Publicado: (1883)

Peripheral macrophages drive CNS disease in the Ndufs4(−/−) model of Leigh syndrome
por: Hanaford, Allison R., et al.
Publicado: (2023)

What Is Climatic Disease?
por: Davies, A. M.
Publicado: (1903)

What Is a Disease?
Publicado: (1886)

Comprehensive Metabolic Profiling of MYC-Amplified Medulloblastoma Tumors Reveals Key Dependencies on Amino Acid, Tricarboxylic Acid and Hexosamine Pathways
por: Pham, Khoa, et al.
Publicado: (2022)

FSMP-18. COMPREHENSIVE METABOLIC PROFILING OF HIGH MYC MEDULLOBLASTOMA REVEALS KEY DIFFERENCES BETWEEN IN VITRO AND IN VIVO GLUCOSE AND GLUTAMINE USAGE
por: Pham, Khoa, et al.
Publicado: (2021)

OTME-9. Comprehensive Metabolic Profiling Of high MYC Medulloblastoma Reveals Key Differences Between In Vitro And In Vivo Glucose And Glutamine Usage
por: Pham, Khoa, et al.
Publicado: (2021)

Orally bioavailable glutamine antagonist prodrug JHU-083 penetrates mouse brain and suppresses the growth of MYC-driven medulloblastoma()()
por: Hanaford, Allison R., et al.
Publicado: (2019)

Riggs’ Disease ; or, “What You Will”
por: Cravens, J. E.
Publicado: (1895)

What Is Mucus? What Is Pus?
por: Noel, H. R.
Publicado: (1868)

Mitochondrial disease in adults: what's old and what's new?
por: Chinnery, Patrick F
Publicado: (2015)

What is hot in infectious diseases?
por: Raoult, Didier
Publicado: (2015)

Kynurenine Pathway in Chronic Kidney Disease: What’s Old, What’s New, and What’s Next?
por: Mor, Adrian, et al.
Publicado: (2020)

What is a disease? What is the disease clinical benign prostatic hyperplasia (BPH)?
por: Foo, Keong Tatt
Publicado: (2019)

Cat scratch disease: What to do with the cat?
por: Okrent Smolar, Avital Lily, et al.
Publicado: (2022)

Emerging diseases--what now?
por: Alleyne, G A
Publicado: (1998)

What Is Vascular Behçet’s Disease?
por: Ishibashi, Hiroyuki
Publicado: (2018)

The gut microbiome in Alzheimer’s disease: what we know and what remains to be explored
por: Chandra, Sidhanth, et al.
Publicado: (2023)

Fibro-Stenosing Crohn’s Disease: What Is New and What Is Next?
por: Solitano, Virginia, et al.
Publicado: (2023)

The French guidelines for alcohol-related liver disease—what’s new, what’s not and what’s still needed
por: Hernández-Tejero, María, et al.
Publicado: (2023)

Animal Models for Fibrotic Liver Diseases: What We Have, What We Need, and What Is under Development
por: Delire, Bénédicte, et al.
Publicado: (2015)

Pre-spillover Prevention of Emerging Zoonotic Diseases: What Are the Targets and What Are the Tools?
por: Childs, James E.
Publicado: (2007)

What about rheumatic diseases and COVID-19?
por: Aouissi, H.A., et al.
Publicado: (2021)

What is hazardous? What is safe?
por: Healy, J W
Publicado: (1978)

Peri-implant disease: what we know and what we need to know
por: Valente, Nicola Alberto, et al.
Publicado: (2016)

Coexisting Coronary and Carotid Artery Disease: What We Did, What Happened
por: Güney, Mehmet Raşit, et al.
Publicado: (2022)

Riggs's Disease—What Is It, and Can It Be Cured?
por: Mills, G. A.
Publicado: (1894)

Primary extramammary invasive Paget’s vulvar disease: what is the standard, what are the challenges and what is the future for radiotherapy?
por: Tolia, Maria, et al.
Publicado: (2016)

What Is Change of Type in Disease?
por: Markham, W. O.
Publicado: (1858)

Coronavirus Disease 2019 in Neonates – What Is Known and What Needs to Be Known
por: Nayak, Manas, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1hbscrr2g8il783djepfnpmeon